Multivariable Analysis of pre-ASCT variables for PFS
| PFS . | |||||
|---|---|---|---|---|---|
| . | Term . | Univariable HR . | Univariable P value . | Multivariable HR . | Multivariable P value . |
| ASC MRD-positive | |||||
| Yes | 2.87 | <.001 | 3.73 | <.001 | |
| Male | |||||
| Male | 1.19 | .44 | |||
| Age (60+) | |||||
| Yes | 1.57 | .04 | 1.30 | .41 | |
| Diagnosis | |||||
| PMBCL | 0.62 | .41 | |||
| TIL | 1.68 | .03 | |||
| Primary refractory | |||||
| Yes | 0.76 | .25 | |||
| Chemo lines | |||||
| 3-4 | 1.43 | .17 | |||
| Pre-ASCT CMR | |||||
| Yes | 0.75 | .19 | |||
| Pre-ASCT DS of 1-3∗ | |||||
| Yes | 0.85 | .67 | |||
| Conditioning | |||||
| CBV | 1.16 | .52 | |||
| Other | 1.10 | .89 | |||
| DHL | |||||
| Yes | 1.75 | .09 | 3.51 | .01 | |
| DEL | |||||
| Yes | 2.10 | .002 | 3.07 | <.001 | |
| PFS . | |||||
|---|---|---|---|---|---|
| . | Term . | Univariable HR . | Univariable P value . | Multivariable HR . | Multivariable P value . |
| ASC MRD-positive | |||||
| Yes | 2.87 | <.001 | 3.73 | <.001 | |
| Male | |||||
| Male | 1.19 | .44 | |||
| Age (60+) | |||||
| Yes | 1.57 | .04 | 1.30 | .41 | |
| Diagnosis | |||||
| PMBCL | 0.62 | .41 | |||
| TIL | 1.68 | .03 | |||
| Primary refractory | |||||
| Yes | 0.76 | .25 | |||
| Chemo lines | |||||
| 3-4 | 1.43 | .17 | |||
| Pre-ASCT CMR | |||||
| Yes | 0.75 | .19 | |||
| Pre-ASCT DS of 1-3∗ | |||||
| Yes | 0.85 | .67 | |||
| Conditioning | |||||
| CBV | 1.16 | .52 | |||
| Other | 1.10 | .89 | |||
| DHL | |||||
| Yes | 1.75 | .09 | 3.51 | .01 | |
| DEL | |||||
| Yes | 2.10 | .002 | 3.07 | <.001 | |
A subset of patients (53/98) had PET imaging available for retrospective assessment using the Deauville scoring system.